(Q37760855)

English

Thiazolidinediones in the treatment of patients with Post-Transplant-Hyperglycemia or new-onset diabetes mellitus after renal transplantation (NODAT) - A new therapeutic option?

scientific article published on April 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20503018%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

Europe PubMed Central

Thiazolidinediones in the treatment of patients with Post-Transplant-Hyperglycemia or new-onset diabetes mellitus after renal transplantation (NODAT) - A new therapeutic option? (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20503018%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20503018%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Marcus D Säemann

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20503018%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

1 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20503018%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Vienna Clinical Weekly

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20503018%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

122

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20503018%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

7-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20503018%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

198-202

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20503018%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

https://scigraph.springernature.com/pub.10.1007/s00508-010-1369-2

0 references

Beta-blockers and progression of coronary atherosclerosis: pooled analysis of 4 intravascular ultrasonography trials.

1 reference

https://api.crossref.org/works/10.1007%2FS00508-010-1369-2

21 January 2018

The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinediones and fractures in men and women

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone prevents sirolimus-induced hypomagnesemia, hypokalemia, and downregulation of NKCC2 protein expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone is associated with mortality in chronic hemodialysis patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinediones: metabolic actions in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinediones

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and Cost of New Onset Diabetes Mellitus Among U.S. Wait-Listed and Transplanted Renal Allograft Recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone treatment of diabetes mellitus after solid organ transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone enhances the antihypertensive and renoprotective effects of candesartan in Zucker obese rats fed a high-protein diet

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone in the management of diabetes mellitus after transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinediones provide better renoprotection than insulin in an obese, hypertensive type II diabetic rat model

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic/pharmacodynamic drug interaction between rosiglitazone and mycophenolate mofetil in kidney transplantation: a case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone therapy of posttransplant diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinediones and Heart Failure: A teleo-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effects of rosiglitazone on the progressive decline in renal function in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between rosiglitazone use and decline in renal function in patients with type 2 diabetes mellitus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of pioglitazone on survival and renal function in a mouse model of polycystic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone protects the pancreatic beta-cell death induced by cyclosporine A.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of TGF-beta expression: a novel role for thiazolidinediones to implement renoprotection in diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of pioglitazone on subclinical atherosclerosis and insulin resistance in nondiabetic renal allograft recipients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Slower decline of renal function after initiation of rosiglitazone in diabetics -- a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sirolimus is associated with new-onset diabetes in kidney transplant recipients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20503018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00508-010-1369-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20503018%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20503018%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37760855&oldid=2100711334"